MedPath

Evaluation of Prevalence of Sexuality Alteration in Women With an Abnormal Pap Test

Not Applicable
Completed
Conditions
Epidemiology
Sexual Dysfunction
Interventions
Other: questionnary
Registration Number
NCT05701020
Lead Sponsor
Centre Hospitalier Universitaire, Amiens
Brief Summary

Human Papilloma virus is the most common sexual infection in women, which can leads to cervical lesion and cervical cancer. Pap test is recommanded in women of 25 years old until 65 years old in order to screen subclinic lesions and improve prognosis. Yet, scientific knowledge about chronic disease showed negative consequences on quality of life.

However, no study until now has striven to evaluate the consequences of an abnormal pap test on sexuality in adult women. The aim of this study is to evaluate if an abnormal pap test have an impact on the sexual functions in women because of the anxiety and psychological consequences of the diagnosis

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • Adult women with an abnormal pap test.
  • Diagnosis known 4 to 12 weeks before the appointment for colposcopy
Exclusion Criteria
  • Cervical cancer
  • Pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Adult women with an abnormal pap testquestionnary-
Primary Outcome Measures
NameTimeMethod
% ofpositive response rate at the first question of the questionnaire18 months
Secondary Outcome Measures
NameTimeMethod
Number of causes of woman alteration sexual function alteration18 months

Trial Locations

Locations (1)

CHU Amiens

🇫🇷

Amiens, France

© Copyright 2025. All Rights Reserved by MedPath